Osteopetrosis is a rare bone disease. It makes bones very hard and dense, almost like stone. This can cause bones to break easily, even from minor bumps. It's sometimes called 'marble bone disease'.
Every report comes from a Lived member, sent anonymously.
Have you had Stem Cell Transplant for Osteopetrosis?
Osteopetrosis, sometimes called marble bone disease, is a group of rare inherited conditions in which bones become abnormally dense but also brittle. Healthy bone is constantly renewed: cells called osteoclasts break down old bone while other cells lay down new bone. In osteopetrosis, osteoclasts are missing or do not work properly, so old bone builds up instead of being replaced. The result is bone that looks heavy and solid on an X-ray yet breaks easily. Denser bone is usually stronger bone, and osteoporosis is the reverse problem of thin, fragile bone; in osteopetrosis the bone is dense but still brittle. The types differ greatly in severity. The most common, autosomal dominant osteopetrosis (also called Albers-Schönberg disease), is usually mild. Some people never have symptoms and learn they have it only when an X-ray is done for another reason. Others develop fractures after minor injuries, curvature of the spine, hip arthritis or bone infections, typically starting in late childhood, adolescence or adulthood. The autosomal recessive form, often called infantile or malignant osteopetrosis (malignant here means severe, not cancer), is much rarer and appears in the first months of life. Overgrown bone crowds out the marrow where blood cells are made, causing anemia, bleeding and frequent infections, and thickened skull bone can pinch the nerves that control sight, hearing and facial movement. Without treatment, this form can be life-threatening in early childhood. An intermediate form falls between the two, usually starting in childhood with fractures and anemia but without severe marrow failure.
Osteopetrosis is caused by changes in genes that osteoclasts need to form or function. At least eight genes are involved. A single gene accounts for about three quarters of cases of the dominant form, and a different gene for about half of the severe infantile cases. In roughly 30 percent of people, the specific genetic cause is not found. Nothing a person or parent does causes the condition. How it runs in families depends on the type. In the dominant form, one altered copy of the gene is enough, so an affected parent has a 50 percent chance of passing it to each child, although severity can vary even within one family. In the recessive form, a child inherits an altered copy from each parent. The parents are usually healthy carriers, and each of their children has a 25 percent chance of being affected. Genetic counseling helps families understand these odds and options for future pregnancies.
X-rays are the main diagnostic tool, because osteopetrosis produces characteristic changes: dense, white-looking bone throughout the skeleton, including the skull and spine. These findings are distinctive enough that X-rays alone usually establish the diagnosis. Infants may first come to attention because of anemia, low blood calcium, an enlarged liver and spleen, poor growth or problems with vision. Genetic testing finds the responsible gene change in most people and matters beyond confirming the diagnosis. It identifies the type, points to complications linked to particular genes and, for infants, helps show whether a stem cell transplant is likely to help. Blood tests check calcium, phosphate, vitamin D, parathyroid hormone and blood counts to look for low calcium and the anemia and low blood cell counts caused by crowded marrow, and magnetic resonance imaging (MRI) of the brain and an eye examination look for nerve compression or fluid buildup around the brain. A bone biopsy is rarely needed.
Treatment depends heavily on the type. For severe infantile osteopetrosis, a hematopoietic stem cell transplant (a bone marrow transplant from a donor) is the only established cure for some children. Because osteoclasts develop from blood-forming stem cells, healthy donor cells can produce working osteoclasts that begin removing bone normally. Results are best when the transplant happens in the first months of life, before nerve damage sets in, because a transplant cannot undo vision loss or brain injury that has already occurred. It carries serious risks, including graft failure, severe infections and dangerously high calcium levels afterward. It also does not help some genetic types, such as rare forms where the defect lies outside the blood-forming cells or forms that cause progressive brain degeneration. Specialized transplant centers weigh these factors with families. Interferon gamma-1b (Actimmune), an injected immune-system protein, is approved by the U.S. Food and Drug Administration to slow the progression of severe infantile osteopetrosis, though it does not replace transplant when transplant is appropriate. For milder forms, there is currently no treatment that changes the underlying disease, so care focuses on preventing and managing complications. Fractures may need surgical repair, which is technically demanding because the abnormal bone complicates surgery and can heal poorly or out of alignment, so an orthopedic surgeon experienced with dense bone is valuable. Good dental care and prompt treatment of jaw infections, correction of low calcium or vitamin D, treatment of anemia, and hearing and vision support all play a role. Experts advise against high doses of calcitriol, an active form of vitamin D once tried as a disease treatment. Gene therapies are being studied but are not yet available.
The outlook varies more by type than for most conditions. Many people with the dominant form live with mild disease, managing occasional fractures, back or hip pain, and dental problems. Because broken bones can heal poorly and are harder to repair surgically, a single fracture can mean a longer recovery than usual, and some people adapt their activities to reduce the risk of falls and heavy impacts. Ongoing follow-up is part of life with any form. Experts recommend regular checks of calcium and mineral levels and blood counts, eye examinations to catch pressure on the optic nerve, hearing assessments and close dental care, since infection of the jaw bone is a characteristic and difficult complication. For children with the severe infantile form, the course depends largely on whether and when a transplant succeeds. Many children survive after transplant, but some keep lasting vision loss or developmental effects from damage that occurred beforehand. Families typically work with a team that includes transplant, endocrine, eye, hearing, dental, orthopedic and genetics specialists.
Arrange an evaluation if X-rays show unusually dense bones, if bones break after minor bumps or falls, or if a family member has been diagnosed and you are considering testing or planning a pregnancy. Contact the care team promptly for changes in vision, new hearing loss or facial weakness, since nerve compression can cause permanent damage. Jaw pain, swelling or a draining sore in the mouth also needs prompt attention because jaw bone infections are harder to treat once established. In infants and children with the severe form, frequent infections, unusual bruising or bleeding, or increasing paleness and tiredness can signal worsening marrow failure and should be reported right away. A seizure or unusual twitching in an infant with the severe form needs emergency care, since low blood calcium can cause it. A suspected fracture, such as new bone pain, swelling or inability to bear weight after an injury, should be assessed the same day.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Osteopetrosis is like, what's helped you, or ask the community a question.